Reported Mar 13, 2024 · Terminated
Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC…
Stason Pharmaceuticals, Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Stason Pharmaceuticals, Inc. · 11 Morgan · Irvine, CA · 92618-2005
Is this the product you have?
- Mercaptopurine Tablets, USP 50 mg
- packaged in
a) 25-count bottle (NDC 69076-913-02)b) 250-count bottle (NDC 69076-913-25)Rx only
- Manufactured forQuinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com
- Lot codes and dates
Lot #: a)22K01222K013A
- Exp
04/30/202423A00123A002A
- Exp
07/31/202423D00623D007A23D007C
- Exp
10/31/2024b)22K013B
- Exp
04/30/202423A002B
- Exp
07/31/202423D007B
- Exp10/31/2024
- Amount recalled
- 54, 131 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Dissolution Specifications: results slightly under spec at at 9-months.
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Stason Pharmaceuticals, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.